You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.

Clinical Advances in

Myeloma: Real World and Future Practice

Evidence shows that there are disparities in multiple myeloma (MM) treatment between clinical trials and real-world outcomes. Awareness of potential practice-changing new data in frontline, maintenance, and relapsed/refractory (RR) MM, new treatment pathways, as well as emerging treatment challenges will provide guidance on how to achieve deep and longer responses based on both clinical and social needs. This collection provides important information and discussions among experts on the latest advances in MM, with the ultimate goal of improving patient outcomes.

Supported by an independent educational grant from

Takeda Pharmaceuticals North America, Inc.

CME Activities

Polling Question

Related Resources

Steering Committee

Graham Jackson, MA, MBBS, FRCP, FRCPath, MD

Graham Jackson, MA, MBBS, FRCP, FRCPath, MD

Steering Committee Chair

University of Newcastle
Newcastle, United Kingdom

Meletios Dimopoulos, MD

Meletios Dimopoulos, MD

University of Athens
Athens, Greece

Hermann Einsele, MD

Hermann Einsele, MD

University Hospital Würzburg
Würzburg, Germany

Sagar Lonial, MD

Sagar Lonial, MD

Emory University
Atlanta, Georgia, United States

Maria-Victoria Mateos, MD, PhD

Maria-Victoria Mateos, MD, PhD

University Hospital of Salamanca
Salamanca, Spain

Philippe Moreau, MD

Philippe Moreau, MD

University Hospital of Nantes
Nantes, France